Ignite Creation Date:
2025-12-24 @ 1:52 PM
Ignite Modification Date:
2026-01-03 @ 11:04 PM
Study NCT ID:
NCT01857895
Status:
COMPLETED
Last Update Posted:
2017-10-19
First Post:
2013-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2013-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-16
First Submit QC Date:
None
Study First Post Date:
2013-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-17
Last Update Post Date:
2017-10-19
Last Update Post Date Type:
ACTUAL